SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001962918-24-000052
Filing Date
2024-05-14
Accepted
2024-05-14 16:22:47
Documents
74
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q slrn-20240331.htm   iXBRL 10-Q 1395522
2 EX-31.1 slrn-20240331x10qexx311.htm EX-31.1 9471
3 EX-31.2 slrn-20240331x10qexx312.htm EX-31.2 9544
4 EX-32.1 slrn-20240331x10qexx321.htm EX-32.1 6162
  Complete submission text file 0001962918-24-000052.txt   6923162

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20240331.xsd EX-101.SCH 56330
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT slrn-20240331_cal.xml EX-101.CAL 70354
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT slrn-20240331_def.xml EX-101.DEF 279540
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20240331_lab.xml EX-101.LAB 591719
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20240331_pre.xml EX-101.PRE 455409
78 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20240331_htm.xml XML 820769
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

IRS No.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41696 | Film No.: 24944734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)